Although, immunotherapy has transformed cancer treatment, it shows limited efficacy in OC, partly due to the immunosuppressive ascitic microenvironment enriched with M2‐polarized TAMs and Tregs.[23] Our findings indicate that CMTM4 fosters an immunosuppressive TME by modulating TAMs, which may compromise the effectiveness of immunotherapy. This evidence concerns the gene CMTM4 and cancer.